The American College of Cardiology Foundation’s National Cardiovascular Data Registry sponsored the study. The ACTION Registry-GWTG is supported in part by the Bristol-Myers Squibb partnership. Dr. Wang reports receiving research grants from the BMS/Sanofi partnership, Schering Plough/Merck, The Medicines Company, Heartscape, Canyon Pharmaceuticals and Eli Lilly/Daiichi Sanyko Alliance, as well as consulting fees/honoraria from Medco and Astra Zeneca. Four of her coauthors report financial relationships with several drug firms.
News
In-Hospital Mortality Risk Increases With DIDO Time for STEMI Patients
Publish date: June 21, 2011
FROM JAMA